Functions of polyphenols and its anticancer properties in biomedical research: a narrative review
Industry Size (2025) USD 8169 Mn Forecast (2035) USD 65364 Mn CAGR (2025 to 2035) 23.1% Obesity GLP-1 Market Forecast and Outlook 2025 to 2035 The obesity GLP-1 market is projected to grow from USD 8169 million in 2025 to approximately USD 65,364 million by 2035, recording an absolute increase of USD 57,195 million over the forecast period
The peptide amount stays the same regardless of water added
In 2023 the FDA placed BPC-157 in Category 2 of its 503A bulk-substances review the group flagged as presenting significant safety risks for compounding reflecting concerns about immunogenicity, impurities, and lack of human data
Schneider-Rauber G, Argenta DF, Caon T
NAD+ IV Improves mood, memory, and concentration Helps with anxiety and depression Reverses signs of aging Helps with weight management Improves mitochondrial function Helps with opioid addiction, PTSD Immunity IV Protects against infection Improves healing time Builds up your immune system Reduces the duration of illnesses Uses: before and after illness, before and after travel, before and after surgery, after injury and others